Firocoxib: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
| IUPAC_name = 3-(Cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one | | IUPAC_name = 3-(Cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one | ||
| image = Firocoxib.png | | image = Firocoxib.png | ||
| image2 = | | image2 = Firocoxibgif | ||
| alt2 = Firocoxib molecule | | alt2 = Firocoxib molecule | ||
Line 58: | Line 58: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Firocoxib''' ([[International Nonproprietary Name|INN]]; brand names '''Equioxx''' and '''Previcox''') is a [[non-steroidal anti-inflammatory drug]] of the [[COX-2 inhibitor]] (coxib) class, currently approved for use in dogs and horses. Firocoxib was the first COX-2 inhibitor approved by the U.S. [[Food and Drug Administration]] for horses.<ref>{{cite web | url = http://www.thehorse.com/ViewArticle.aspx?ID=9896 | title = New NSAID Equioxx (firocoxib) Approved by USEF | date = July 2, 2007 | accessdate = 2008-04-18 | work = The Horse}}</ref> Firocoxib is not intended or approved for use in human medicine.<ref>[http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/veterinary/000142/WC500065936.pdf Equioxx], European Medicines Agency</ref> | '''Firocoxib''' ([[International Nonproprietary Name|INN]]; brand names '''Equioxx''' and '''Previcox''') is a [[non-steroidal anti-inflammatory drug]] of the [[COX-2 inhibitor]] (coxib) class, currently approved for use in dogs and horses. Firocoxib was the first COX-2 inhibitor approved by the U.S. [[Food and Drug Administration]] for horses.<ref>{{cite web | url = http://www.thehorse.com/ViewArticle.aspx?ID=9896 | title = New NSAID Equioxx (firocoxib) Approved by USEF | date = July 2, 2007 | accessdate = 2008-04-18 | work = The Horse}}</ref> Firocoxib is not intended or approved for use in human medicine.<ref>[http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/veterinary/000142/WC500065936.pdf Equioxx], European Medicines Agency</ref> | ||
Line 72: | Line 69: | ||
[[Category:Dog health]] | [[Category:Dog health]] | ||
[[Category:Lactones]] | [[Category:Lactones]] | ||
[[Category:Sulfones]] | [[Category:Sulfones]] | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | [[Category:Non-steroidal anti-inflammatory drugs]] | ||
[[Category:Furans]] | [[Category:Furans]] | ||
[[Category:Ethers]] | [[Category:Ethers]] | ||
[[Category:Drug]] | [[Category:Drug]] |
Revision as of 15:54, 8 April 2015
![]() | |
Firocoxib molecule | |
Clinical data | |
---|---|
Trade names | Equioxx; Previcox |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATCvet code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C17H20O5S |
Molar mass | 336.402 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Firocoxib |
Articles |
---|
Most recent articles on Firocoxib |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Firocoxib at Clinical Trials.gov Clinical Trials on Firocoxib at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Firocoxib
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Firocoxib Discussion groups on Firocoxib Directions to Hospitals Treating Firocoxib Risk calculators and risk factors for Firocoxib
|
Healthcare Provider Resources |
Causes & Risk Factors for Firocoxib |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Firocoxib (INN; brand names Equioxx and Previcox) is a non-steroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, currently approved for use in dogs and horses. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses.[1] Firocoxib is not intended or approved for use in human medicine.[2]
References
- ↑ "New NSAID Equioxx (firocoxib) Approved by USEF". The Horse. July 2, 2007. Retrieved 2008-04-18.
- ↑ Equioxx, European Medicines Agency
- Pages with script errors
- Pages with broken file links
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Dog health
- Lactones
- Sulfones
- Non-steroidal anti-inflammatory drugs
- Furans
- Ethers
- Drug